Optimising Cancer Immunotherapy: Challenges and Opportunities
نویسندگان
چکیده
1. prIME Oncology, Atlanta, Georgia, USA 2. prIME Oncology, The Hague, Netherlands; University of Sheffield, Weston Park Hospital, Sheffield, UK 3. Gustave Roussy, Villejuif, France 4. Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain 5. Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands 6. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 7. Ludwig Center for Cancer Research, Lausanne, France 8. Barts Cancer Institute, Queen Mary University of London, London, UK 9. German Cancer Research Forum (DKTK), Medical University of Essen, Essen, Germany 10. Netherlands Cancer Institute, Amsterdam, Netherlands 11. Karolinska Institutet, Stockholm, Sweden 12. University of Siena, Siena, Italy 13. Universität Duisburg-Essen, Essen, Germany
منابع مشابه
Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
Triple negative breast cancer (TNBC): challenges and solutions via the immune cells TNBC is one of the most complicated types of breast cancer to treat. It is generally diagnosed based on the absence of three receptors: estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2) and is thus defined as a triple negative. TNBC is often more aggressive with lower survival rates...
متن کاملOPTIMISING CANCER IMMUNOTHERAPY: CHALLENGES AND OPPORTUNITIES Summary of Presentations from a prIME Oncology Scientific Exchange on 21st May 2016 in Amsterdam, Netherlands Authors
1. prIME Oncology, Atlanta, Georgia, USA 2. prIME Oncology, The Hague, Netherlands; University of Sheffield, Weston Park Hospital, Sheffield, UK 3. Gustave Roussy, Villejuif, France 4. Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain 5. Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands 6. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 7. Ludwig Center...
متن کاملImmunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
Cancer treatments have been transformed with recent advances in cancer immunotherapy.1 As monotherapies, these agents have demonstrated clinical activity across many tumor types. Further advances in the effectiveness of cancer immunotherapies will require targeting antitumor immune response at multiple levels, which may be accomplished through combination approaches. This review discusses the c...
متن کاملAddressing current challenges in cancer immunotherapy with mathematical and computational modeling
The goal of cancer immunotherapy is to boost a patient’s immune response to a tumor. Yet, the design of an effective immunotherapy is complicated by various factors, including a potentially immunosuppressive tumor microenvironment, immune-modulating effects of conventional treatments, and therapy-related toxicities. These complexities can be incorporated into mathematical and computational mode...
متن کاملAddressing current challenges in cancer immunotherapy with mathematical and computational modelling.
The goal of cancer immunotherapy is to boost a patient's immune response to a tumour. Yet, the design of an effective immunotherapy is complicated by various factors, including a potentially immunosuppressive tumour microenvironment, immune-modulating effects of conventional treatments and therapy-related toxicities. These complexities can be incorporated into mathematical and computational mod...
متن کامل